Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts
June 24 2022 - 10:00AM
Business Wire
Pfizer Inc. (NYSE: PFE) invites investors and the general public
to view and listen to a webcast of a conference call with
investment analysts at 10 a.m. EDT on Thursday, July 28, 2022. The
purpose of the call is to provide an update on Pfizer’s results, as
reflected in the company’s Second Quarter 2022 Performance Report,
to be issued that morning.
To view and listen to the webcast and view the Performance
Report, visit our web site at www.pfizer.com/investors. Information
on accessing and registering for the webcast will be available at
www.pfizer.com/investors beginning today. Participants are advised
to register in advance of the conference call.
You can also listen to the conference call by dialing either
800-456-4352 in the United States and Canada or 785-424-1086
outside of the United States and Canada. The password is
“PFEQ222”.
The transcript and webcast replay of the call will be made
available on our web site at www.pfizer.com/investors within 24
hours after the end of the live conference call and will be
accessible for at least 90 days.
About Pfizer: Breakthroughs That Change Patients’
Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
more than 170 years, we have worked to make a difference for all
who rely on us. We routinely post information that may be important
to investors on our website at www.Pfizer.com. In addition, to
learn more, please visit us on www.Pfizer.com and follow us on
Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us
on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, our
anticipated operating and financial performance, reorganizations,
business plans, strategy and prospects; expectations for our
product pipeline, in-line products and product candidates,
including anticipated regulatory submissions, data read-outs, study
starts, approvals, clinical trial results and other developing
data, revenue contribution, growth, performance, timing of
exclusivity and potential benefits; strategic reviews; capital
allocation objectives; dividends and share repurchases; plans for
and prospects of our acquisitions, dispositions and other business
development activities, and our ability to successfully capitalize
on these opportunities; manufacturing and product supply; and our
efforts to respond to COVID-19, including the Pfizer-BioNTech
COVID-19 vaccine (Comirnaty) and our oral COVID-19 treatment
(Paxlovid), that are subject to substantial risks and uncertainties
that could cause actual results to differ materially from those
expressed or implied by such statements. A description of these
risks and uncertainties can be found in Pfizer’s Annual Report on
Form 10-K for the fiscal year ended December 31, 2021 and in its
subsequent reports on Form 10-Q, including in the sections thereof
captioned “Risk Factors” and “Forward-Looking Information and
Factors That May Affect Future Results”, as well as in its
subsequent reports on Form 8-K, all of which are filed with the
U.S. Securities and Exchange Commission and available at
www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
Category: Finance
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220624005022/en/
Media: PfizerMediaRelations@Pfizer.com +1 (212) 733-1226
Investors: IR@Pfizer.com +1 (212) 733-4848
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Sep 2023 to Sep 2024